Clinical Trials Sponsored by Karin High

Total 451 results

Karin High
University of Kentucky

Terminated

Effect of Acetyl-L-carnitine on Chronic Pancreatitis

Chronic Pancreatitis

United States
High Point University

Recruiting

The Effect of Combining Pain Neuroscience Education and Transcranial Direct Current Stimulation on Pain Catastrophizing, Kinesiophobia, and Pain in Patients With Chronic Low Back Pain

Chronic Low-back Pain | Catastrophizing Pain | Kinesiophobia

United States
High Point University

Terminated

The Diagnostic Accuracy of the Clinical Examination

Musculoskeletal Pain | Musculoskeletal Injury

United States
High Point University

Completed

Real-time Optimized Biofeedback Utilizing Sport Techniques (ROBUST)

Knee Injuries
High Point University

Completed

Utilizing the Trunk as a Proximal Lever to Strengthen the Hip Musculature and Alter Lower Extremity Function

Patellofemoral Pain Syndrome

United States
High Point University

Completed

Conservative Management of Femoroacetabular Impingement

Femoroacetabular Impingement

United States
High Point University

Completed

Do Common Physical Tests Predict Injury or Performance (TEAM)

Lower Extremity Musculoskeletal Injury

United States
High Point University

Completed

Benefits of Traditional and Golf-specific Resistance Training in Amateur Female Golfers

Improved Performance in Amateur Female Golfers (MESH Term: Body Composition)

United States
High Point University

Completed

Neurocognitive Visual Reaction Training

Reaction Time

United States
High Point Pharmaceuticals, LLC.

Terminated

A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects

Obesity | Overweight

United States
John Jay High School

Unknown

How Neurofibromatosis Type 1 (NF1) Affects Schoolwork and Self-Esteem

Neurofibromatosis Type 1

United States
High Point Pharmaceuticals, LLC.

Terminated

Safety Study of HPP854 in Subjects With Mild Cognitive Impairment or a Diagnosis of Mild Alzheimer's Disease

Mild Cognitive Impairment | Mild Alzheimer's Disease

United States
High Point Pharmaceuticals, LLC.

Terminated

Safety Study of HPP593 in Subjects During and After Limb Immobilization

Muscle Atrophy | Hypodynamia

United States
High Point Regional Health Systems

Completed

B Vitamins in MTHFR Positive Patients With Major Depression: A Post Hoc Analysis of Findings (BVMD)

Depression
IRCCS San Raffaele
High Research

Recruiting

Sacituzumab Govitecan, Preceding Radical Cystectomy, in Treating Patients With Muscle-invasive Bladder Cancer

Urothelial Carcinoma

Italy
High Point University
University of Otago

Unknown

Mixed Methods Study Protocol_Chronic Pain and Marginalized Populations

Chronic Pain | Marginalization, Social

United States
High Point University
Adidas International, Inc.

Completed

Changes in Footwear Comfort and Performance in High School Football Players

Foot | Footwear

United States
University of Copenhagen
Ubberup Folk High School

Completed

Physiological Factors That Influence Maintenance of Lifestyle Changes and Weight Loss - a Longitudinal Study

Obesity | Overweight

Denmark
Shanghai Mental Health Center
Changchun Huayang High-tech Co., Ltd; Jiangsu Sheneryang High-tech Co., Ltd

Unknown

Octohydroaminoacridine Succinate Tablet for Mild-to-Moderate Alzheimer's Disease

Alzheimer Disease

China
High Point Clinical Trials Center
Ferox Therapeutics

Terminated

Insulin Tolerance Test Study in Patients With Type 1 Diabetes

Hypoglycemia | Type 1 Diabetes

United States
Pharmanex
Dermatology Consulting Services, High Point NC

Completed

Efficacy of a Nutritional Supplement on Skin Health in Generally Healthy Adults

Skin Health

United States
Kyowa Kirin, Inc.
Kyowa Kirin Co., Ltd.

Completed

Study of KRN23 in Adults With X-linked Hypophosphatemia (XLH)

X-linked Hypophosphatemia

United States, Korea, Republic of, Japan, Ireland, United Kingdom, France, Italy
Kyowa Kirin, Inc.
Kyowa Kirin Co., Ltd.

Completed

Efficacy and Safety of Burosumab (KRN23) Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With X Linked Hypophosphatemia (XLH)

X-Linked Hypophosphatemia

Korea, Republic of, Canada, United States, Australia, Japan, United Kingdom, Sweden
Kyowa Kirin, Inc.
Kyowa Kirin Co., Ltd.

Completed

Study of KRN23 (Burosumab), a Recombinant Fully Human Monoclonal Antibody Against Fibroblast Growth Factor 23 (FGF23), in Pediatric Subjects With X-linked Hypophosphatemia (XLH)

X-linked Hypophosphatemia

Netherlands, United States, United Kingdom, France
Pharmanex
Dermatology Consulting Services, High Point NC

Not yet recruiting

Study to Assess Impact of Dietary Supplement on Sleep Health

Sleep
Pharmanex
Dermatology Consulting Services, High Point NC

Completed

Nutritional Supplement Efficacy on Cellular Protection and Skin Health in Generally Healthy Adults

Skin Health

United States
University of Copenhagen
Ubberup Folk High School

Completed

Physiological Factors That Influence Maintenance of Lifestyle Changes and Weight Loss - a Cross-sectional Study

Obesity | Overweight

Denmark
University of Copenhagen
Ubberup Folk High School

Completed

The Effect of Repeated Lifestyle Intervention on Weight Loss Maintenance

Obesity | Overweight

Denmark
Kyowa Kirin, Inc.
Kyowa Kirin Co., Ltd.

Completed

Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)

X-linked Hypophosphatemia

United States, Korea, Republic of, Canada, Japan, France, Denmark
Kyowa Kirin, Inc.
Kyowa Kirin Co., Ltd.

Completed

Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis

United States, Canada, Germany, Japan
University of California, Los Angeles
High Q Foundation

Completed

Examination of Quantitative Electroencephalographic (QEEG) Biomarkers in Huntington's Disease (HD)

Huntington's Disease

United States
Karin Schindler

Completed

Infant Nutrition in Austria (Sukie)

Breast Feeding

Austria
Kyowa Hakko Kirin Pharma, Inc.

Terminated

Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Study of KW-2449 in Acute Myelogenous Leukemia (AML) (Protocol Number: 2449-US-002)

Acute Myelogenous Leukemia (AML)

United States
Kyowa Hakko Kirin Pharma, Inc.

Terminated

Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer

Colorectal Cancer

United States
Kyowa Hakko Kirin Pharma, Inc.

Terminated

Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast Cancer

Breast Cancer

United States
Kyowa Hakko Kirin Pharma, Inc.

Completed

A Study of KRN23 in X-linked Hypophosphatemia

X-linked Hypophosphatemia

United States
Kyowa Hakko Kirin Pharma, Inc.

Terminated

Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer

Neoplasms | Ovarian Neoplasms | Fallopian Tube Neoplasms | Primary Peritoneal Neoplasm

United States
Kyowa Hakko Kirin Pharma, Inc.

Completed

Safety Study to Evaluate KW-2450 in Subjects With Advanced Solid Tumor

Solid Tumor

United States
Kyowa Kirin, Inc.
Kyowa Kirin Co., Ltd.

Completed

Long-Term Extension Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia (XLH)

X-Linked Hypophosphatemia

United States
Kyowa Hakko Kirin Pharma, Inc.
Kyowa Kirin Co., Ltd.

Completed

An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia

X-linked Hypophosphatemia

United States, Canada
Kyowa Hakko Kirin Pharma, Inc.
Kyowa Kirin Co., Ltd.

Completed

A Study to Evaluate Abuse Potential of Istradefylline

Drug Abuse

United States
Kyowa Kirin, Inc.

Recruiting

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema

Diabetic Macular Edema (DME)

United States, Japan, Korea, Republic of, Australia
Kyowa Kirin, Inc.

Active, not recruiting

Mogamulizumab Q4week Dosing in Participants With R/R CTCL

Cutaneous T-Cell Lymphoma Refractory | Cutaneous T-Cell Lymphoma, Relapsed

United States, United Kingdom, Spain, France, Italy
Kyowa Kirin, Inc.

Completed

Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL

Cutaneous T-Cell Lymphoma

United States, Spain, France, Australia, Switzerland, United Kingdom, Japan, Denmark, Germany, Italy, Netherlands
Kyowa Kirin, Inc.

Completed

Single-dose Study to Investigate the Plasma PK of KW-6356 and Its Major Metabolite

Hepatic Impairment

United States
Kyowa Kirin, Inc.

Completed

Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-KW-6356

Healthy Male Subjects

United States
Kyowa Kirin, Inc.

Completed

A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa

Parkinson's Disease

United States
Alexandria University
High Institute of Public Health, Egypt

Completed

The Relationship Between Helicobacter Pylori Infection and Inflammatory Bowel Diseases: A Real-life Observation

Inflammatory Bowel Diseases | Helicobacter Pylori Infection

Egypt
Kyowa Hakko Kirin Pharma, Inc.
Kyowa Kirin Co., Ltd.

Completed

A 12-week Randomized Study to Evaluate Oral Istradefylline in Subjects With Moderate to Severe Parkinson's Disease (KW-6002)

Idiopathic Parkinson's Disease

United States, Canada, Czechia, Germany, Israel, Italy, Poland, Serbia
Kyowa Hakko Kirin Pharma, Inc.
Kyowa Kirin Co., Ltd.

Completed

A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia

X-linked Hypophosphatemia

United States, Canada

Clinical Trials Sponsored by Karin High

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations